Delivery Order SPE2DB20D3103-SPE2DB25FQ3M8
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $9.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,159.11 to AmerisourceBergen Drug Corp for the supply of Aspirin-Dipyridamole Extended Release 25-200 mg tablets (60 count) on August 13, 2025, with completion scheduled for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate...
- On September 16, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,157.03 to AmerisourceBergen Drug Corp for Aspirin-Dipyridamole ER 25-200 mg tablets in units of 60 supplied through a firm fixed-price contract. The award is being performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order represents a non-set-aside competitive award with an ultimate completion date of September 17, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,625.92 to AmerisourceBergen Drug Corp for the supply of Ticagrelor 90 mg tablets (60-count units) on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, non-set-aside contract utilized firm fixed pricing and identified Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $41,762.73 for ORSERDU 345 mg tablets (30-count units) from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 29, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Brilinta 60 mg tablets (60-count packaging) with a ceiling value of $2,829.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationships with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,924.78 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The order, issued under contract number 4568856529, calls for the delivery of Esomeprazole 20mg tablets (90-count supply) with a firm fixed price arrangement and an ultimate completion date of August 18, 2025. This is a non-set-aside competitive award executed as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orserdu 345 mg tablets (30-count packages) with a ceiling value of $27,841.82. This firm fixed-price delivery order, which is scheduled for completion by October 6, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...